Boston Scientific has announced it has received FDA approval its INGENIO and ADVANTIO pacemakers and INVIVE cardiac resynchronization therapy pacemakers, according to a news release. The INGENIO and ...
Zacks Investment Research on MSN
M&A Strategy Strengthens Boston Scientific's Growth Prospects
Over the past several years, Boston Scientific BSX has pursued a series of acquisitions in support of its growth strategy, both strengthening its core businesses and expanding into high-growth ...
(RTTNews) - Boston Scientific Corp. (BSX) said it has received U.S. Food and Drug Administration approval for the navigation-enabled FARAWAVE NAV Ablation Catheter for the treatment of paroxysmal ...
Boston Scientific has signed a definitive agreement for the acquisition of an Ajax Health company, Cortex, to bolster its cardiac ablation portfolio. The companies did not disclose the financial terms ...
The 2025 Appropriate Use Criteria for implantable cardioverter-defibrillators (ICD) and cardiac resynchronization therapy (CRT), and pacing have been released. This year’s guideline is broader than ...
New FARAWAVE™ NAV Ablation Catheter and FARAVIEW™ Software combine with OPAL HDx™ Mapping System to provide visualization during pulsed field ablation Today, physicians may utilize a separate mapping ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback